News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
709,544 Results
Type
Article (42012)
Company Profile (331)
Press Release (667201)
Section
Business (210217)
Career Advice (2083)
Deals (36600)
Drug Delivery (100)
Drug Development (82890)
Employer Resources (171)
FDA (16508)
Job Trends (15367)
News (355589)
Policy (33839)
Tag
Academia (2574)
Alliances (51263)
Alzheimer's disease (1308)
Approvals (16469)
Artificial intelligence (178)
Bankruptcy (364)
Best Places to Work (11737)
Biotechnology (213)
Breast cancer (207)
Cancer (1557)
Cardiovascular disease (128)
Career advice (1742)
CAR-T (108)
Cell therapy (318)
Clinical research (66486)
Collaboration (590)
Compensation (312)
COVID-19 (2621)
C-suite (136)
Data (1483)
Diabetes (193)
Diagnostics (6286)
Earnings (86724)
Employer resources (149)
Events (113224)
Executive appointments (502)
FDA (17297)
Funding (526)
Gene therapy (227)
GLP-1 (658)
Government (4460)
Healthcare (18921)
Infectious disease (2718)
Inflammatory bowel disease (118)
Interviews (320)
IPO (16671)
Job creations (4052)
Job search strategy (1488)
Layoffs (445)
Legal (8336)
Lung cancer (228)
Manufacturing (224)
Medical device (13319)
Medtech (13324)
Mergers & acquisitions (20183)
Metabolic disorders (514)
Neuroscience (1682)
NextGen: Class of 2025 (6631)
Non-profit (4519)
Northern California (1882)
Obesity (293)
Opinion (211)
Patents (137)
People (58617)
Phase I (20606)
Phase II (29253)
Phase III (21925)
Pipeline (618)
Postmarket research (2652)
Preclinical (8740)
Radiopharmaceuticals (244)
Rare diseases (302)
Real estate (6244)
Regulatory (22641)
Research institute (2361)
Resumes & cover letters (358)
Southern California (1626)
Startups (3716)
United States (16878)
Vaccines (599)
Weight loss (210)
Date
Today (173)
Last 7 days (421)
Last 30 days (1967)
Last 365 days (35362)
2025 (1838)
2024 (35806)
2023 (40630)
2022 (51797)
2021 (56329)
2020 (54794)
2019 (47400)
2018 (35771)
2017 (33137)
2016 (32662)
2015 (38615)
2014 (32517)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (776)
Arizona (210)
Asia (40276)
Australia (6443)
California (4288)
Canada (1568)
China (372)
Colorado (196)
Connecticut (208)
Europe (85733)
Florida (609)
Georgia (147)
Illinois (424)
Indiana (250)
Maryland (695)
Massachusetts (3340)
Michigan (185)
Minnesota (319)
New Jersey (1204)
New York (1212)
North Carolina (808)
Northern California (1882)
Ohio (155)
Pennsylvania (1007)
South America (1159)
Southern California (1626)
Texas (630)
Utah (122)
Washington State (435)
709,544 Results for "enanta pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Enanta Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 8, 2025
·
1 min read
Press Releases
Enanta Pharmaceuticals to Appeal Ruling Related to ‘953 Patent Infringement Lawsuit
December 24, 2024
·
3 min read
Genetown
Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 30, 2024
Enanta Pharmaceuticals, Inc. announced that effective April 29, 2024, the Compensation Committee of Enanta Pharmaceuticals’ Board of Directors granted employment inducement awards to Matthew P. Kowalsky, Enanta’s new Chief Legal Officer.
April 30, 2024
·
3 min read
Genetown
Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference
Enanta Pharmaceuticals, Inc. today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, and Tara L. Kieffer, Ph.D., Chief Product Strategy Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 5, 2024 at 7:30 a.m. ET in New York, NY.
May 29, 2024
·
1 min read
Business
Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
Enanta Pharmaceuticals, Inc., a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, announced the appointment of Matthew P. Kowalsky, J.D., as Chief Legal Officer.
April 30, 2024
·
4 min read
Genetown
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
Enanta Pharmaceuticals, Inc. today announced that data from the company’s SPRINT study of EDP-235 has been accepted for a poster presentation at ESCMID Global 2024 (formerly ECCMID) being held April 27–30 in Barcelona, Spain.
April 17, 2024
·
2 min read
Genetown
Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference 2024
Enanta Pharmaceuticals, Inc. announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, and Tara L. Kieffer, Ph.D., Chief Product Strategy Officer, will participate in a fireside chat at the JMP Securities Life Sciences Conference on May 14, 2024 at 10:00 a.m. ET in New York, NY.
May 7, 2024
·
1 min read
Press Releases
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2024
November 25, 2024
·
14 min read
Press Releases
Enanta Pharmaceuticals to Present Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for Respiratory Syncytial Virus (RSV)
December 9, 2024
·
6 min read
Business
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today reported financial results for its fiscal second quarter ended March 31, 2024.
May 6, 2024
·
12 min read
1 of 70,955
Next
